Role of beclin 1-dependent autophagy in cardioprotection of ischemic preconditioning

Abstract

Emerging evidence indicates that ischemic preconditioning (IPC) induces autophagy which attenuates myocardial ischemia/reperfusion (I/R) injury. However, the precise mechanisms remain complex and unclear. The present study was to investigate which autophagy pathway was involved in the cardioprotection induced by IPC, so that we can acquire an attractive treatment way for ischemic heart disease. Adult male Sprague-Dawley (SD) rats were randomly divided into sham group, I/R group and IPC group. IPC was induced with three cycles of 5 min regional ischemia alternating with 5 min reperfusion in a heart I/R model. Samples were taken from the center of the infracted heart and examined by using the electron microscopy, the terminal deoxynucleotidyl transferase-mediated nick end-labeling (TUNEL) method, Western blotting and co-immunoprecipitation (Co-IP). A large number of autophagic vacuoles were observed in the cardiomyocytes of IPC group as compared with I/R group. LC3-II formation, an autophagy marker, was up-regulated in IPC group as compared with I/R group (P<0.05). Moreover, the interaction between Beclin 1 and Bcl-2 was significantly increased in IPC group as compared with I/R group (P<0.01). It was also found that IPC decreased I/R-induced apoptosis (P<0.01). These results suggest that IPC inhibits Beclin 1-dependent excessive autophagy in reperfusion phase and cooperates with anti-apoptosis pathway to diminish the cell death induced by the myocardial I/R injury.

Keywords

autophagy / acute myocardial ischemia-reperfusion injury / ischemic preconditioning / Beclin 1 / Bcl-2

References

[1] BraunwaldE., KlonerR.A.. Myocardial reperfusion: a double-edged sword?. J Clin Invest, 1985, 76(5): 1713-1719

[2] DepreC., VatnerS.F.. Cardioprotection in stunned and hibernating myocardium. Heart Fail Rev, 2007, 12(3–4): 307-317

[3] KostinS., PoolL., ElsässerA., et al.. Myocytes die by multiple mechanisms in failing human hearts. Circ Res, 2003, 92(7): 715-724

[4] HeinS., ArnonE., KostinS., et al.. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation, 2003, 107(7): 984-991

[5] GottliebR.A., FinleyK.D., MentzerR.M.Jr.. Cardioprotection requires taking out the trash. Basic Res Cardiol, 2009, 104(2): 169-180

[6] LevineB., KroemerG.. Autophagy in the pathogenesis of disease. Cell, 2008, 132(1): 27-42

[7] MaiuriM.C., ZalckvarE., KimchiA., et al.. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol, 2007, 8(9): 741-752

[8] MizushimaN., LevineB., CuervoA.M., et al.. Autophagy fights disease through cellular self-digestion. Nature, 2008, 451(7182): 1069-1075

[9] Rodriguez-EnriquezS., KimI., CurrinR.T., et al.. Tracker dyes to probe mitochondrial autophagy (mitophagy) in rat hepatocytes. Autophagy, 2006, 2(1): 39-46

[10] BoyaP., González-PoloR.A., CasaresN., et al.. Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol, 2005, 25(3): 1025-1040

[11] LumJ.J., BauerD.E., KongM., et al.. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell, 2005, 120(2): 237-248

[12] LeeJ., GiordanoS., ZhangJ.. Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem J, 2012, 441(2): 523-540

[13] GustafssonA.B., GottliebR.A.. Mechanisms of apoptosis in the heart. J Clin Immunol, 2003, 23(6): 447-459

[14] Hamacher-BradyA., BradyN.R., LogueS.E., et al.. Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy. Cell Death Differ, 2007, 14(1): 146-157

[15] YanL., VatnerD.E., KimS.J., et al.. Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci USA, 2005, 102(39): 13 807-13 812

[16] Hamacher-BradyA., BradyN.R., GottliebR.A.. Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J Biol Chem, 2006, 281(40): 29 776-29 787

[17] RyterS.W., LeeS.J., SmithA., et al.. Autophagy in vascular disease. Proc Am Thorac Soc, 2010, 7(1): 40-47

[18] PattingreS., TassaA., QuX., et al.. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell, 2005, 122(6): 927-939

[19] ItakuraE., KishiC., InoueK., et al.. Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Mol Biol Cell, 2008, 19(12): 5360-5372

[20] FuruyaN., YuJ., ByfieldM., et al.. The evolutionarily conserved domain of Beclin 1 is required for Vps34 binding, autophagy and tumor suppressor function. Autophagy, 2005, 1(1): 46-52

[21] ObersteinA., JeffreyP.D., ShiY.. Crystal structure of the Bcl-XL-Beclin 1 peptide complex: Beclin 1 is a novel BH3-only protein. J Biol Chem, 2007, 282(17): 13 123-13 132

[22] MaiuriM.C., Le ToumelinG., CriolloA., et al.. Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin1. EMBO J, 2007, 26(10): 2527-2539

[23] OhS., XiaofeiE., NiD., et al.. Downregulation of autophagy by Bcl-2 promotes MCF7 breast cancer cell growth independent of its inhibition of apoptosis. Cell Death Differ, 2011, 18(3): 452-464

[24] HuangC., YitzhakiS., PerryC.N., et al.. Autophagy induced by ischemic preconditioning is essential for cardioprotection. J Cardiovasc Transl Res, 2010, 3(4): 365-373

[25] YangX., CohenM.V., DowneyJ.M.. Mechanism of cardioprotection by early ischemic preconditioning. Cardiovasc Drugs Ther, 2010, 24(3): 225-234

[26] DowneyJ.M., KriegT., CohenM.V.. Mapping preconditioning’s signaling pathways: an engineering approach. Ann N Y Acad Sci, 2008, 1123: 187-196

[27] JonesS.P., BolliR.. The ubiquitous role of nitric oxide in cardioprotection. J Mol Cell Cardiol, 2006, 40(1): 16-23

[28] PainT., YangX.M., CritzS.D., et al.. Opening of mitochondrial K^(ATP) channels triggers the preconditioned state by generating free radicals. Circ Res, 2000, 87(6): 460-466

[29] MatsuiY., TakagiH., QuX., et al.. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res, 2007, 100(6): 914-922

[30] BrocheriouV., HagègeA.A., OubenaïssaA.. Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury. J Gene Med, 2000, 2(5): 326-333

[31] ImahashiK., SchneiderM.D., SteenbergenC.. Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolicacidification during ischemia, and reduces ischemia/reperfusion injury. Circ Res, 2004, 95(7): 734-741

[32] HochhauserE., KivityS., OffenD., et al.. Bax ablation protects against myocardial ischemia-reperfusion injury in transgenic mice. Am J Physiol Heart Circ Physiol, 2003, 284(6): H2351-H2359

[33] LevineB., SinhaS., KroemerG.. Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy, 2008, 4(5): 600-606

[34] LiangC., FengP., KuB., et al.. Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat Cell Biol, 2006, 8(7): 688-699

[35] ZhuY., ZhaoL., LiuL., et al.. Beclin 1 cleavage by caspase-3 inactivates autophagy and promotes apoptosis. Protein Cell, 2010, 1(5): 468-477